CAR-T cell therapy targeting surface expression of TYRP1 to treat cutaneous and rare melanoma subtypesSameeha Jilani(University of California, Los Angeles), Cristina Puig-Saus(APLA Health)Nature CommunicationsFebruary 9, 202410.1038/s41467-024-45221-2Cited by 50SaveCiteExport RISWatch citationsRelated PapersKey Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction|Cell|2020|534Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma|Cancer Cell|2020|379